![](/img/cover-not-exists.png)
IDALOPIRDINE, A 5-HT6 ANTAGONIST IN PHASE III DEVELOPMENT AS ADJUNCTIVE THERAPY TO CHOLINESTERASE INHIBITORS IN PATIENTS WITH MILD-TO-MODERATE ALZHEIMER’S DISEASE: BASELINE DATA FROM THE ONGOING STARSHINE STUDY
Atri, Alireza, Boneva, Neli, Cummings, Jeffrey L., Frölich, Lutz, Tariot, Pierre N., Windfeld, KristianVolume:
12
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2016.06.803
Date:
July, 2016
File:
PDF, 49 KB
english, 2016